EMJ Cardiology 10 [Supplement 3] . 2022

In this issue

Highlighting a plenary session that took place at the European Atherosclerosis Society (EAS), this article summarises the groundbreaking research and personalised approach to atherosclerotic cardiovascular disease. The presenters covered the deep phenotyping of atherosclerotic disease, including the use of single-cell technologies, to understand the immune mechanisms involved in cardiovascular disease.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given